Patents Assigned to HETERO LABS LIMITED
  • Process for the preparation of angiotensin II receptor blockers
    Patent number: 11655220
    Abstract: A process is disclosed for preparing sartan drugs including intermediates thereof, which avoids formation of Nitrosoamine impurities.
    Type: Grant
    Filed: April 7, 2021
    Date of Patent: May 23, 2023
    Assignee: Hetero Labs Limited
    Inventors: Kura Rathnakar Reddy, Nagabelli Murali, Nimmanapalli Pullareddy
  • Stable pharmaceutical product and vessel comprising sodium picosulfate, magnesium oxide and citric acid
    Patent number: 11471447
    Abstract: Described herein is a stable oral liquid pharmaceutical product comprising sodium picosulfate, magnesium oxide and citric acid. Particularly, sodium picosulfate is physically separated from magnesium oxide and citric acid prior to dispensing and is mixed at the time of administration.
    Type: Grant
    Filed: June 9, 2020
    Date of Patent: October 18, 2022
    Assignee: HETERO LABS LIMITED
    Inventors: Parthasaradhi Reddy Bandi, Khadgapathi Podile, Sunil Deviprasad Tiwari, Vijay Nasare, Prakash Shetiya, Patchigolla Satyanarayana Rao, Chidara Ravi Chandra Gupta
  • Anti-retroviral compositions
    Patent number: 11045423
    Abstract: The present invention relates to pharmaceutical antiretroviral compositions comprising a combination of antiretroviral agents (darunavir, dolutegravir and ritonavir), the manufacturing process thereof and use of the said compositions for the prevention, treatment or prophylaxis of HIV infection.
    Type: Grant
    Filed: July 27, 2017
    Date of Patent: June 29, 2021
    Assignee: HETERO LABS LIMITED
    Inventors: Parthasaradhi Reddy Bandi, Khadgapathi Podile, Sunil Deviprasad Tiwari, Prakash Shetiya, Balakrishnaiah Medum
  • C-3 novel triterpenone with C-17 reverse amide derivatives as HIV inhibitors
    Patent number: 11034718
    Abstract: The invention relates to C-3 novel triterpenone with C-17 reverse amide derivatives, related compounds, and pharmaceutical compositions useful for the therapeutic treatment of viral diseases and particularly HIV mediated diseases.
    Type: Grant
    Filed: November 19, 2019
    Date of Patent: June 15, 2021
    Assignee: HETERO LABS LIMITED
    Inventors: Bandi Parthasaradhi Reddy, Gazula Levi David Krupadanam, Adulla Panduranga Reddy, Kasireddy Bhaskar Reddy, Lanka VL Subrahmanyam, Kura Rathnakar Reddy
  • Stable bilayer tablet compositions
    Patent number: 11020351
    Abstract: The invention relates to stable bilayer tablet compositions comprising empagliflozin, linagliptin and pharmaceutically acceptable excipients which show no incompatibilities and the compositions having good stability and superior dissolution profile.
    Type: Grant
    Filed: August 14, 2018
    Date of Patent: June 1, 2021
    Assignee: HETERO LABS LIMITED
    Inventors: Parthasaradhi Reddy Bandi, Khadgapathi Podile, Sunil Deviprasad Tiwari, Srinivasa Rao Gella
  • C-3 novel triterpenone with C-28 urea derivatives as HIV inhibitors
    Patent number: 10669305
    Abstract: The present invention relates to C-3 novel triterpenone with C-28 urea derivatives of formula (I); or pharmaceutically acceptable salts, pharmaceutically acceptable solvates, pharmaceutically acceptable hydrates, tautomers, stereoisomers, prodrugs, compositions or combination thereof, wherein R1, R2, R3, W, J and X are as defined herein. The present invention also relates to pharmaceutical compositions comprising compounds of formula (I) useful for the treatment of viral diseases and particularly HIV mediated diseases.
    Type: Grant
    Filed: October 12, 2016
    Date of Patent: June 2, 2020
    Assignee: HETERO LABS LIMITED
    Inventors: Parthasaradhi Reddy Bandi, Rathnakar Reddy Kura, David Krupadanam Gazula Levi, Panduranga Reddy Adulla, Bhaskar Reddy Kasireddy, Carl Thomas Wild, David Eugene Martin, Theodore John Nitz
  • Stable tablet compositions of Sacubitril: Valsartan
    Publication number: 20200078309
    Abstract: The present invention relates to pharmaceutical compositions of sacubitril; valsartan sodium and a process for the preparation thereof. Particularly, the present invention relates to stable non-aqueous based tablet composition of sacubitril; valsartan sodium and a process for the preparation thereof.
    Type: Application
    Filed: September 11, 2019
    Publication date: March 12, 2020
    Applicant: Hetero Labs Limited
    Inventors: Parthasarathi Reddy BANDI, Khadgapathi PODILE, Sunil Deviprasad TIWARI, Naresh ANAPARTY
  • STABLE ORAL LIQUID COMPOSITIONS OF ENALAPRIL
    Publication number: 20190336478
    Abstract: The present invention relates to pharmaceutical compositions of enalapril, particularly stable oral liquid compositions comprising enalapril, one or more buffering agents and at least one pharmaceutically acceptable excipient.
    Type: Application
    Filed: May 3, 2019
    Publication date: November 7, 2019
    Applicant: HETERO LABS LIMITED
    Inventors: Parthasaradhi Reddy BANDI, Khadgapathi PODILE, Sunil Deviprasad TIWARI, Prakash SHETIYA, Satyanarayana Rao PATCHIGOLLA, Ravi Chandra Gupta CHIDARA
  • C-3 novel triterpenone with C-28 amide derivatives as HIV inhibitors
    Patent number: 10370405
    Abstract: The invention relates to C-3 novel triterpenone with C-28 amide derivatives, related compounds, and pharmaceutical compositions useful for the therapeutic treatment of viral diseases and particularly HIV mediated diseases (formula 1).
    Type: Grant
    Filed: March 12, 2016
    Date of Patent: August 6, 2019
    Assignee: HETERO LABS LIMITED
    Inventors: Parthasaradhi Reddy Bandi, Rathnakar Reddy Kura, David Krupadanam Gazula Levi, Panduranga Reddy Adulla, Eswara Rao Bammidi, Bhaskar Reddy Kasireddy, Sudhakar Neela, Carl Thomas Wild, David Eugene Martin, Theodore John Nitz
  • Betulinic proline imidazole derivatives as HIV inhibitors
    Patent number: 9868758
    Abstract: The present invention relates to novel betulinic proline imidazole derivatives and related compounds, compositions useful for therapeutic treatment of viral diseases and particularly HIV mediated diseases.
    Type: Grant
    Filed: June 29, 2015
    Date of Patent: January 16, 2018
    Assignee: HETERO LABS LIMITED
    Inventors: Parthasaradhi Reddy Bandi, Rathnakar Reddy Kura, Panduranga Reddy Adulla, David Krupadanam Gazula Levi, Eswara Rao Bammidi, Ranga Reddy, Carl Thomas Wild, David Eugene Martin, Theodore John Nitz